Pharma Investment Still Strong in U.K. R&D Despite Brexit

GALWAY, IRELAND--July 11, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Investment in the U.K.'s pharmaceutical sector remains strong despite the future uncertainty of Brexit.

Within this article: Details investment in U.K. R&D, trends, potential impact of Brexit on healthcare, warnings from leading pharma giants